Friday, Aug. 28, 2015, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $47.90 to $8,027,410.00.

Highlighted Stocks Traded by Insiders:

Cimpress (CMPR) - FREE Research Report

Blake Katryn, who is Pres, Vistaprint Business Unit at Cimpress, sold 579 shares at $70.00 on Aug. 28, 2015. Following this transaction, the Pres, Vistaprint Business Unit owned 14,146 shares meaning that the stake was reduced by 3.93% with the 579-share transaction.

The shares most recently traded at $73.24, up $3.24, or 4.42% since the insider transaction. Historical insider transactions for Cimpress go as follows:

  • 4-Week # shares sold: 2,660
  • 12-Week # shares sold: 4,765
  • 24-Week # shares sold: 15,842

The average volume for Cimpress has been 502,400 shares per day over the past 30 days. Cimpress has a market cap of $2.3 billion and is part of the services sector and diversified services industry. Shares are down 1.84% year-to-date as of the close of trading on Friday.

Cimpress N.V. aggregates small and individually customized orders for print, signage, apparel, and similar products worldwide. The company conducts its operations through Vistaprint Business Unit and All Other Business Unit segments. The company has a P/E ratio of 25.7. Currently, there are 2 analysts who rate Cimpress a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMPR - FREE

TheStreet Quant Ratings

rates Cimpress as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and weak operating cash flow. Get the full

Cimpress Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AerCap Holdings (AER) - FREE Research Report

Jonkhart Marius, who is Director at AerCap Holdings, bought 1,500 shares at $40.00 on Aug. 28, 2015. Following this transaction, the Director owned 6,500 shares meaning that the stake was boosted by 30% with the 1,500-share transaction.

The shares most recently traded at $41.84, up $1.84, or 4.4% since the insider transaction. Historical insider transactions for AerCap Holdings go as follows:

  • 4-Week # shares sold: 1,603
  • 12-Week # shares sold: 1,603
  • 24-Week # shares sold: 1,603

The average volume for AerCap Holdings has been 3.3 million shares per day over the past 30 days. AerCap Holdings has a market cap of $8.2 billion and is part of the services sector and transportation industry. Shares are up 8.86% year-to-date as of the close of trading on Friday.

AerCap Holdings N.V., an independent aircraft leasing company, engages in the leasing, financing, sale, and management of commercial aircraft and engines. The company has a P/E ratio of 6.8. Currently, there are 7 analysts who rate AerCap Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Recommends

Exclusive Offer: Get the latest Stock Analysis on AER - FREE

TheStreet Quant Ratings

rates AerCap Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and a generally disappointing performance in the stock itself. Get the full

AerCap Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

NeuroMetrix (NURO) - FREE Research Report

Higgins Thomas T, who is Senior Vice President, CFO at NeuroMetrix, bought 4,500 shares at $0.92 on Aug. 28, 2015. Following this transaction, the Senior Vice President, CFO owned 85,494 shares meaning that the stake was boosted by 5.56% with the 4,500-share transaction.

Historical insider transactions for NeuroMetrix go as follows:

  • 4-Week # shares bought: 21,800
  • 12-Week # shares bought: 39,657
  • 24-Week # shares bought: 39,657

The average volume for NeuroMetrix has been 292,700 shares per day over the past 30 days. NeuroMetrix has a market cap of $9.8 million and is part of the health care sector and health services industry. Shares are down 52.81% year-to-date as of the close of trading on Friday.

NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease and spinal stenosis, and diabetes. Currently, there is 1 analyst who rates NeuroMetrix a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NURO - FREE

TheStreet Quant Ratings

rates NeuroMetrix as a

sell

. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

NeuroMetrix Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.